Results
1 -
10 of
66Drugu2013Drug Interactions Between the Anti-Hepatitis??C Virus 3D Regimen of Ombitasvir, Paritaprevir/Ritonavir, and Dasabuvir and Eight Commonly Used Medications in Healthy Volunteers, Clinical Pharmacokinetics Drugu2013Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications, Clinical Pharmacokinetics Hepatitis B and Hepatitis C Antiviral Agents, Drug Interactions in Infectious Diseases: Antimicrobial Drug Interactions Management of HCV Infection, Handbook of Hepatitis C Emerging Antivirals in the Future, Hepatitis C Virus Treatment Therapie der Hepatitis??C, Der Internist Suspected pharmacokinetic interaction between raltegravir and the 3D regimen of ombitasvir, dasabuvir and paritaprevir/ritonavir in an HIV-HCV liver transplant recipient, European Journal of Clinical Pharmacology Natural occurrence of NS5B inhibitor resistance-associated variants in Brazilian patients infected with HCV or HCV and HIV, Archives of Virology Prevalence of NS5B resistance-associated variants in treatment-na??ve Asian patients with chronic hepatitis C, Archives of Virology Progress in eradication of HCV in HIV positive patients with significant liver fibrosis in Vienna, Wiener klinische Wochenschrift